In addition to PD-L1 in malignant cells interfering with cytotoxic T-cell function, of the binding of PD-L1 to PD-1 increases tumor cell resistance to conventional chemotherapy and increases tumor cell proliferation and survival 6. This evidence concerns the gene CD274 and neoplasm.